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We characterized and compared the characteristics of Ca
2+
movements through the sarcoplasmic reticulum of inferior
oblique muscles in the various conditions including primary
inferior oblique overaction (IOOA), secondary IOOA, and
controls, so as to further understand the pathogenesis of pri-
mary IOOA. Of 15 specimens obtained through inferior ob-
lique myectomy, six were from primary IOOA, 6 from secon-
dary IOOA, and the remaining 3 were controls from enu-
cleated eyes. Ryanodine binding assays were performed, and
Ca
2+ uptake rates, calsequestrins and SERCA levels were de-
termined. Ryanodine bindings and sarcoplasmic reticulum
Ca
2+ uptake rates were significantly decreased in primary
IOOA (p<0.05). Western blot analysis conducted to quantify
calsequestrins and SERCA, found no significant difference
between primary IOOA, secondary IOOA, and the controls.
Increased intracellular Ca
2+ concentration due to reduced
sarcoplasmic reticulum Ca
2+ uptake may play a role in pri-
mary IOOA.
Key Words: Calcium, calsequestrin, inferior oblique overac-
tion, ryanodine receptor, sarcoplasmic reticulum, sarcoplasmic
reticulum Ca
2+-ATPase 1
INTRODUCTION
Inferior oblique overaction (IOOA), defined as
an elevation of an eye as it moves toward adduc-
tion, is a common oculomotor disease.
1 From the
clinical point of view, it has been customary to
distinguish between primary and secondary over-
actions of this muscle. Secondary overactions
differ in as much that the vertical deviation is
large in the primary position and is accompanied
by a torsional deviation and the Bielschowsky
head tilt test is positive. Although the clinical
differentiation of primary and secondary overac-
tion is not difficult, the explanations given for
apparent primary overaction in the older litera-
ture are vague. Secondary overaction is caused by
paresis or paralysis of the ipsilateral superior
oblique muscle or by paresis or paralysis of the
contralateral superior rectus muscle. However,
primary overaction, in which there is no evidence
for past or present ipsilateral superior oblique
muscle paralysis or paresis, is difficult to explain.
A number of studies have been undertaken to
elucidate the pathogenesis of primary IOOA.
1-5
However, none of the resulting explanations are
convincing, and it remains doubtful as to whether
a true primary overaction exists at all from an
innervational perspective.
Ca
2+ ions trigger muscle contraction and the
release of Ca
2+ from the sarcoplasmic reticulum
(the intracellular Ca
2+ storage site) plays an im-
portant role in determining the intramuscular Ca
2+
concentration. Ca
2+ binds with the protein partici-
pating in muscle contraction to induce muscle
contraction and is then reabsorbed into the
sarcoplasmic reticulum via Ca
2+ ATPase. In addi-
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tion, muscle relaxation is possible when Ca
2+ is
reabsorbed by the sarcoplasmic reticulum and
during this process Ca
2+-ATPase (the Ca
2+ pump)
plays a key role. This process of Ca
2+ uptake by
the sarcoplasmic reticulum via Ca
2+-ATPase re-
duces intramuscular Ca
2+ concentrations and re-
sults in muscle relaxation.
6,7
Several regulatory proteins present in the
sarcoplasmic reticulum plays fundamental roles in
regulating the intramuscular concentration of
Ca
2+. These include ryanodine receptor, a Ca
2+
release channel which participates in Ca
2+ release
from sarcoplasmic reticulum into muscle cells,
Ca
2+-ATPase, which drives Ca
2+ uptake, and
calsequestrin that binds with Ca
2+.
8-11 Thus, since
Ca
2+ uptake by the sarcoplasmic reticulum and
Ca
2+ release from the sarcoplasmic reticulum play
key roles in the regulation of Ca
2+ concentrations
in muscle cells, the above proteins are important
elements in studies on the mechanisms of muscle
contraction and relaxation. Furthermore, changes
in these proteins may be of key importance in
many muscular diseases. Reported studies on
diseases associated with the dysfunction of the
ryanodine receptor mainly concern with heart
disease, although studies concerning its involve-
ment with skeletal muscle in malignant hyper-
thermia, myasthenia gravis, and muscular dys-
trophy have been conducted. However, little is
known about its relation with extraocular
muscles.
12-21
In the present study, Ca
2+ release, uptake, and
storage, were examined in inferior oblique muscles
with primary or secondary overaction, and com-
pared with those of the normal inferior oblique
muscles, particularly with respect to Ca
2+ move-
ments through the sarcoplasmic reticulum so as to
further understand the pathogenesis of primary
IOOA.
MATERIALS AND METHODS
The inferior oblique muscles of patients diag-
nosed as having primary or secondary IOOA were
obtained through a weakening procedure (myec-
tomy) under general anesthesia. IOOA was
graded according to the amount of eye over-
elevation in adduction versus the position of the
fellow eye: 1+ represented an over-elevation of
1mm, 2+ 2 mm, 3+ 3 mm, and 4+ 4 mm. Patients
with an IOOA 3+ or 4+ underwent inferior ob-
lique weakening surgery for functional or cos-
metic reasons. Those who had a history of other
ocular disease or who had undergone previous
ocular surgery were excluded. Three patients (6
eyes) had primary IOOA and 9 (10 eyes) sec-
ondary IOOA. Additional inferior oblique muscles
(normal controls) were obtained from 4 patients (4
eyes) who underwent enucleation due to phthisis
bulbi. Patients' ages ranged from 3 to 71 years and
there were 10 males and 6 females. All surgical
procedures were performed by one of the authors
(JBL), and each muscle specimen was obtained at
the same location from the muscle insertion with
minimal manipulation. Although procedures were
performed in all 16 patients, muscle homogena-
tion was possible in 12 patients. Muscles were
frozen in liquid nitrogen immediately after the
procedure, and muscle tissues were homogenized
in a cold room at -4 .
Preparation of whole homogenates
After removing blood and connective tissues
from the inferior oblique muscles in 0.9% NaCl
solution, the muscle specimens were dried with
filter paper and weighed. About 50 mg of inferior
oblique muscle tissue per ml of homogenate
buffer was placed in solution (20 mM morpholino-
propanesulphonic acid, 1 M KCl, leupeptin 1 M, μ
pepstatin 1 M, aprotinine 1 μ M, PMSF 0.1 μ mM,
trypsin inhibitor 10 M/ml, sucrose 0.3 μ M), and
the mixture was homogenated for 3 × 30 sec
using a polytron PT probe (Brinkmann Instru-
ments Co, Westburg, NY, USA). Total protein was
assayed by the Bradford method.
22
Characteristics of ryanodine receptor in primary
and secondary IOOA
Whole homogenate (2.5 mg) was placed in
buffer solution [1 M KCl, 20 mM morpholinopr-
opanesulphonic acid (pH 7.4), 20 nM [
3H]ryano-
dine (54.7 Ci/mmol, New England Nuclear Co,
Billerica, MA, USA), 1mM EGTA] at 37 for 2
hours to determine ryanodine binding value (total
binding value). After blocking ryanodine receptorCalcium Uptake and Release in Inferior Oblique Overaction
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in the sarcoplasmic reticulum, the same amounts
of whole homogenate and non-labeled ryanodine
were placed into the buffer solution to obtain the
'non-specific binding value'. The following reac-
tions were performed upon the two ryanodine
containing homogenates mentioned above. 100 l μ
of PEG solution [30% PEG, 1 mM EDTA Tris (pH
7.4)] was added to homogenate and left at room
temperature for 5 min. The mixture was then
centrifuged for 15 min at 14,000 rpm to precipitate
sarcoplasmic reticulum, and the supernatant was
washed with 0.4 ml of ryanodine binding buffer
solution. Soluen 350 (100 l) was then added to μ
the precipitate to dissolve the lipid layer from the
sarcoplasmic reticulum. The mixture was left at 7
0 for 15 min and moved to a scintillation vial
to measure radioactivity after adding 4 ml of
picofluor.
Uptake of oxalate-supported Ca
2+ by sarcoplasmic
reticulum
In order to load Ca
2+ into the sarcoplasmic retic-
ulum, the reaction mixture [KCl 100 mM, mor-
pholinopropanesulphonic acid (pH 6.8) 20 mM,
NaN3 10 mM,] was added to 300 g of whole μ
homogenate and reacted for 4 min at 37 . 5 mM
of MgATP, 10 mM potassium oxalate, and 0.2 mM
45CaCl2 0.2 mM (104 cpm/nmol; Amersham, Ar-
lington Height, IL, USA) were then added and the
whole was filtered through a Minipore filter (0.45
m pore size) for 2, 4, or 7 min. The filtrants were μ
placed into scintillation vials to measure radioac-
tivity after adding 4 ml of picofluor and left for 15
min.
Western blot analysis of calsequestrin and sarco-
endoplasmic reticulum Ca
2+-ATPase 1 (SERCA1)
Calsequestrin is a 65 KDa protein which stores
Ca
2+ in the sarcoplasmic reticulum. SERCA 1 is a
120 KDa enzyme which is related with fast mus-
cle. After quantifying the amount of protein by
Bradford method, 50 g of protein was mixed μ
with sample buffer and boiled at 95 for 5 min.
Proteins were separated by electrophoresis, and
blotted onto nitrocellulose paper using buffer
solution. The paper was then placed in a
blocking solution containing phosphate buffered
saline (PBS) containing 5% bovine serum al-
bumin and 0.1% Tween 20 for an hour at room
temperature. Primary antibody (mouse mono-
clonal anti-human antibody; Department of Bio-
science, Kwangju Science and Research Institute,
Kwangju, Korea) for calsequestrin and primary
antibody (mouse monoclonal anti-human anti-
body; Transduction Laboratories, Lexington, KY,
USA) for SERCA1 were reacted for 3 hours at
room temperature. The proteins were washed
with PBS containing 0.1% Tween 20 3 times, and
reacted for 90 minutes at room temperature with
secondary antibody (alkaline phosphatase-con-
jugated goat anti-mouse IgG; Santa Cruz, CA,
USA). Protein bands were detected by enhanced
chemiluminescence (Amersham Life Science, Little
Chalfont, England, UK).
Statistical analysis
The above procedure was repeated eight times.
All measured values are expressed as means ±
standard deviations. Comparisons between the
three groups were performed using the Kruscal-
Wallis test and comparison between two groups
using the Wilcoxon rank sum test; p values of <
0.05 were considered statistically significant.
RESULTS
Ryanodine binding measurement
Ryanodine receptor binding was measured in
the whole homogenate of each inferior oblique
muscle tissue. The amount of ryanodine receptor
binding per unit of protein was the greatest for
the control group, followed by the secondary
IOOA group and then the primary IOOA group.
Specific binding between ryanodine receptor and
ryanodine in the primary IOOA group was sig-
nificantly lower than that in the control group,
suggesting that the activity of the ryanodine
receptor in the primary IOOA group was lower
than that in the control group (Table 1). How-
ever, no significant difference in receptor bind-
ing properties was observed between the other
two group combinations (p>0.05).Hee Seon Kim, et al.
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Uptake of Ca
2+ by the sarcoplasmic reticulum
The rate of Ca
2+ -uptake by the sarcoplasmic
reticulum was the fastest for the control group,
followed by the secondary IOOA group, and then
the primary IOOA group. The difference between
all three groups was statistically significant (p<
0.05). More specifically, Ca
2+ reabsorbed into
sarcoplasmic reticulum was fastest for the control
group and slowest for the primary IOOA group
(Table 2), and all intergroup differences were sig-
nificant.
Western blot analysis for calsequestrin and
SERCA1
Differences between the Ca
2+ storage capacities
of the sarcoplasmic reticulum in the oblique
muscles of each of the three groups were esti-
mated by determining the amount of calsequetrin.
No significant inter-group differences were ob-
served in terms of the amount of calsequestrin
(Fig. 1). In order to determine whether a lower
Ca
2+ uptake was due to the down-regulation of
SERCA1 (Ca
2+pump), western blot analysis was
performed. However, no significant difference
was observed between the three groups with
respect to SERCA1 expression (Fig. 2).
Table 1. Concentration of the Ryanodine Receptor in the Sarcoplasmic Reticulum of Inferior Oblique Muscles
No. of eyes [
3H] Ryanodine binding (fmole/mg protein)
Control 3 51.11 ± 13.34
Primary IOOA 6 27.29 ± 15.58*
Secondary IOOA 6 43.65 ± 18.48
Values are means ± standard deviations.
IOOA, inferior oblique overaction.
*Statistically significant difference when compared with the control (p<0.05).
Table 2. The Rate of
45Ca
2+ Uptake by the Sarcoplasmic Reticulum of Inferior Oblique Muscles
Group No. of eyes
45Ca
2+ uptake rate
Control 3 46.23 ± 5.07
Primary IOOA 6 17.83 ± 2.87*
Secondary IOOA 6 27.72 ± 4.85*
Values are means ± standard deviations.
IOOA, inferior oblique overaction.
*Ca
2+ uptake rates (nmole/mg protein/min) were significantly different in the three groups (p<0.05).
Fig. 1. The expression of calsequestrin in inferior oblique
muscles. C, P, and S represent inferior oblique muscles
from the controls, and primary and secondary inferior
oblique overaction cases, respectively. These three groups
were similar with respect to calsequestrin expression.
Fig. 2. The expressions of sarco-endoplasmic reticulum
Ca
2+-ATPase 1 in inferior oblique muscles. C, P, and S
represent inferior oblique muscles from the controls, and
primary and secondary inferior oblique overaction cases,
respectively. No significant difference was found between
these three groups in terms of SERCA1 expression.Calcium Uptake and Release in Inferior Oblique Overaction
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DISCUSSION
A number of hypotheses have been proposed
concerning the pathogenesis of primary IOOA.
Bielschowsky, for instance, suggested that eyes
are elevated in adduction due to an abnormal
fascial structure of the inferior oblique muscle.1
Guibor suggested that IOOA could be caused by
a synkinesis of inferior oblique muscle with the
ipsilateral medial rectus muscle owing to an im-
pulse spread within the central nervous system.
4
Spencer and McNeer reported that an electron
microscopic structure of the inferior oblique mus-
cle showed no difference between primary and
secondary IOOA, and concluded primary IOOA
might be due to incomplete palsy of the ipsilateral
superior oblique muscle.
5 The discovery of muscle
pulleys has directed our attention to other etio-
logic possibilities for this apparent overaction.
3
The distribution of the isoforms of lactate dehy-
drogenase in children with IOOA was different
from that in the control group.
2
In the present study, we evaluated the func-
tional affinity of the ryanodine receptor by at-
taching the [
3H] to ryanodine. Moreover, because
muscle contractility in primary IOOA is presumed
to be larger than that of normal controls, intra-
muscular Ca
2+ concentrations in primary IOOA
are expected to be higher than normal, which sug-
gests Ca
2+ release by the sarcoplasmic reticulum is
enhenced. However, unexpectedly, ryanodine
receptor binding affinity, which resulted in Ca
2+-
release, was significantly low in the primary
IOOA compared with that in the controls. Thus,
we postulated that, in primary IOOA, the Ca
2+
storage within the sarcoplasmic reticulum is
reduced due to Ca
2+-ATPase inactivation, and that
consequently Ca
2+-release capacity is reduced. As
a result, the amount or the function of ryanodine
receptor was supposed to be reduced. However,
other investigators have reported that the inac-
tivation of Ca
2+-ATPase is closely related with
ischemic heart disease, heart failure, and hyper-
trophy of cardiac muscle; thus, as the intracellular
Ca
2+ concentration increases, the concentration of
ryanodine receptor decreases, and in some cases,
down regulation has been found to be associated
with the decreased expression of its mRNA.
23,24
By measuring Ca
2+ uptake using oxalate, we
were able to determine the amount of Ca
2+ seques-
tration by the sarcoplasmic reticulum and to
estimate the function of the ryanodine receptor
indirectly. In the present study, the amount and
rate of Ca
2+ uptake was determined when the
ryanodine receptor was completely blocked.
Moreover, uptake rate differences between the
three groups were significant. Ca
2+ was reab-
sorbed most promptly in control group, followed
by the secondary IOOA group, and the primary
IOOA group. This result is consistent with our
assumption that if Ca
2+ is not sequestered rapidly
into the sarcoplasmic reticulum, but remains in
the cytoplasm, that the intracellular Ca
2+ concen-
tration would be highest in primary IOOA muscle
cells. In secondary IOOA, the rate of Ca
2+ uptake
was slower than that of the control group, which
suggests that this is a transitional phenomenon,
which results from the relative overaction of the
inferior oblique muscle due to paralysis of its
antagonist, the superior oblique muscle.
Ca
2+ pump activity is known to be reduced in
muscular dystrophy and in Brody disease.
22,25
However, little information is available on the role
of Ca
2+ pump in ocular disease, especially in
oculomotor disease, although it was reported that
Ca
2+ pump activity changes in lens epithelial cells
after treated with an oxidant or heat.
26 In the
present study, Ca
2+ pump levels, which is one of
the factors that impacts the Ca
2+ uptake rate, were
assayed by western blotting for SERCA 1, a fast
twitch isoform of SERCA. However, no significant
difference was found between the three groups.
Thus we infer that a reduction in Ca
2+ uptake in
IOOA is not due to reduced Ca
2+ pump levels, but
rather is probably due to a functional abnormality
in SERCA 1, or in phospholamban, a SERCA
regulator, or alternatively to a reduced level of
ATP phosphorylation. Further studies are needed
to resolve this issue.
Calsequestrin is a Ca
2+ storage protein that
binds Ca
2+ within the lumen of the sarcoplasmic
reticulum. The protein is usually fixed in the junc-
tional sarcoplasmic reticulum and located near the
ryanodine receptor. Calsequestrin is negatively
charged and interacts with the positively charged
triadin and ryanodine receptors. Furthermore,
calsequestrin has been reported to be related to
Ca
2+-ATPase present in the sarcoplasmic reticu-Hee Seon Kim, et al.
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lum.
27,28 In the present study, no significant dif-
ference was found between the three groups with
respect to calsequestrin expression, which sug-
gests that Ca
2+ concentrations in the sarcoplasmic
reticulum might not be different between groups.
However, this does not exclude the possibility
that Ca
2+ storage capacity in the sarcoplasmic
reticulum by calsequestrin is impaired.
In the present study, we attempted to unravel
the mechanism of IOOA from a molecular per-
spective rather than from the anatomical or his-
tological standpoints. Thus, we evaluated ryano-
dine receptor binding, Ca
2+ uptake, the relation
between SERCA and uptake, and calsequestrin
(Ca
2+ storage), in normal, primary IOOA, and
secondary IOOA. Initially we hypothesized that
the pathogenesis of IOOA (especially in primary
IOOA) is associated with changes in intracellular
Ca
2+ concentration and Ca
2+ movement. The ob-
served delay in Ca
2+ uptake by the sarcoplasmic
reticulum in primary IOOA seems remarkable.
However, this study has some limitations. First,
age-matched controls are required to exclude the
possibility of age-related changes in Ca
2+ signaling
or, may be, in tissue stability. Second, the number
of sample is small. Last, there are many other
proteins involved in the Ca
2+ signaling and con-
traction in muscles that would deserve a closer
analysis. Further study is needed to determine
whether delayed Ca
2+ uptake per se has a causal
relationship on increased intracellular Ca
2+ con-
centration. Moreover, a significant reduction in
ryanodine receptor binding was also observed in
primary IOOA. Thus, the simultaneous measure-
ments of intracellular Ca
2+ concentration and mus-
cle contraction, and functional analysis of regu-
lating protein abnormalities require further inves-
tigation.
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